As a leading European medicines wholesaler to European independent pharmacists and as an owner and franchisee of community pharmacies, McKesson Europe makes a real difference to the healthcare of millions of people every day. We operate in markets and healthcare environments that are highly regulated, giving us a unique insight into healthcare policy across 12 European countries. We would therefore like to share our vision and views on key healthcare issues with policy makers, associations and other interested stakeholders
On 12 September 2017, Celesio AG has officially announced its renaming to McKesson Europe AG. Documents of Celesio AG remain documents of McKesson Europe AG.
Celesio believes that pharmacists are ideally placed to make significant cost savings and outcomes improvements to support public healthcare budgets. One area where immediate savings are possible is pharmacist-led generic substitution.
Celesio believes that pharmaceutical distributors are a vital link in Europe’s medicines supply chain. They provide enormous value for patients by delivering a huge range of medicines within short time frames and across wide geographical areas. They also provide hidden value for healthcare ...
Celesio believes that patient deserve better healthcare outcomes. Allowing pharmacists read-write access with consent to patient´s data can help to achieve these aims and reduce costs for healthcare systems. This Position Paper explains why enabling read-write access by community pharmacists, ...
Celesio believes that Europe’s community pharmacies remain an under-used resource. This Position Paper explains how community pharmacies are more than capable of offering cost-effective healthcare solutions to relieve the growing burden on healthcare systems, while contributing to better overall ...